Starting at $599 / 12 week plan Installment pricing available

You should seek medical advice promptly if you: Are currently prescribed testosterone and are considering joining a retatrutide clinical trial Have noticed symptoms of hormonal imbalance such as fatigue, mood changes, reduced libido, or unexpected weight changes while on either treatment Have a history of polycythaemia, liver disease, prostate conditions, or cardiovascular disease, as these may affect suitability for either treatment Are sourcing retatrutide from unregulated online suppliers, which carries serious risks of counterfeit or contaminated products Seek urgent medical attention call 999 or use NHS 111 if you experience: Chest pain, palpitations, or breathlessness Severe, persistent upper abdominal pain (particularly if it radiates to the back), vomiting, or jaundice, which may indicate pancreatitis or gallbladder disease For those already on testosterone therapy through the NHS or a regulated private provider, it is important to inform your prescribing clinician of any new treatments including investigational drugs so that monitoring plans can be adjusted accordingly

Support GLP-1 Patented Eriomin lemon bioflavonoid complex is clinically studied to support healthy GLP-1 production.
The fat loss peptides resource page and anti-aging peptides page also offer useful starting points for exploring related compounds that may complement either approach
Documented areas of research interest include: Melanocortin receptor (MC1R to MC5R) agonism and signalling Melanogenesis and melanocyte biology in cell models (MC1R) MC4R-mediated appetite and energy-balance pathways in animal models All research applications are non-clinical
These medications necessitate careful selection and monitoring by healthcare providers due to the potential for side effects and specific application criteria, such as genetic testing for eligibility